Paul Mampilly has an almost uncanny knack for predicting winners in the stock market before they take off, and he has a record to prove it. His success is not a matter of luck, however. Instead, it is the result of the hours that he and his team devote to extensive research. His history in the market records one successful investment after another with managing some accounts worth millions of dollars and others that are much more modest.
Any stock that Paul Mampilly picks must retain the promise that he saw in it originally even after 30 to 40 hours of intense research. He spends another 20 to 30 hours in preparing his written recommendation. The time and effort that he devotes to the process provide the basis for his ability to choose a stock that does well as a winning pick. His recent investment recommendations focus on food delivery services, electric vehicles and precision medicine.
Choosing Food Preferences as a Guide to Stock Selection
Pew Research shows that millennials now constitute the nation’s largest living generation, a fact that Mampilly notes in his stocks that represent food preferences. Mampilly sees their preferences for food delivery services as an opportunity to make money in the market. Prepared food deliveries, meal kits and grocers who deliver weekly are experiencing increases in sales. Special services such as Plated and Blue Apron provide a complete set of ingredients for a meal along with instructions for preparing them.
Mampilly expects significant changes in the food and grocery industry as the young group’s preferences become the norm. Big Food, as he likes to call Kellogg’s, General Mills, Campbell Soups, Kraft, Coca-Cola and others, does not engender the respect from the younger generation that preceding groups gave it. While Boomers favor giant supermarkets and fast, convenient food, the millennial generation still likes that too, but they want it to contain healthy nutrition. Their position as America’s most well-educated generation with 37 percent of them having a college degree, they understand the importance of diet in obesity, diabetes and metabolic diseases. Companies that can respond to their demands stand to make significant gains in the stock market. They like to eat, as the average $50.75 per week that they spend on eating out indicates. They like to prepare nutritious, gourmet meals, but they do not like to shop the traditional grocery stores for the ingredients to do so.
Connect with Paul Mampilly on LinkedIn for more information.
Gearing Up for Electric Vehicles
Mampilly’s prediction that traditional car manufacturers such as Ford, Chrysler and some Japanese companies as well are on a fast track to oblivion may seem stunning, but he bases it on a comparison of cell phones before and after the introduction of the iPhone. He calls it an “iPhone moment” because of the rapid change in perception of the devices’ capabilities. Most users are unable to remember the status of the cell phone industry when the only thing that an instrument did was send and receive calls. He predicts that an “iPhone moment” is going to similarly affect the automobile industry, changing the way that people perceive the capabilities of vehicles and instantaneously increase expectations. He anticipates that the “moment” is rapidly approaching with the release of Tesla’s Model 3, an event that he expects to affect the market.
As the first mass-market, self-driving electric car, it has the potential to have an impact that is as far-reaching as the Ford Model T at the beginning of the 20th century. A boost that the Ford never had is the availability of the Tesla for an internet purchase, a convenience that lets buyers bypass traditional automobile dealers. The design of an electric transmission that has no more than three parts has a lower need for upkeep than a complex structure that has many more parts. Mampilly shares his opinion that avoiding automobile and automobile-related stocks is the wise thing to do.
Focusing on Precision in Medicine
Mampilly anticipates a change in “one-size-fits-all” health care concepts as precision medicine replaces them. By using a patient’s genetic information or genomes along with medical history to search for a match against a massive database, a doctor has an aid in diagnosing conditions. He envisions patients receiving a genetic diagnostic test to reaffirm the doctor’s opinion and a treatment regimen that precisely addresses unique symptoms.
Companies that can develop a capability in precision medicine have the opportunity to become leaders in the medical field, potentially replacing the industry giants like Pfizer and Merck. Mampilly’s Profits Unlimited service includes five precision-medicine-based stocks for subscribers to consider adding to a balanced portfolio. One of them has already had an increase of more than 70 percent in just a few months.
Benefiting from Mampilly’s Extraordinary Market Acumen
With achievements on Wall Street than many only dream of, Paul Mampilly walked away to put his knowledge to use in helping the average investor earn significant returns. After serving as a hedge fund manager and winning the Templeton Foundation competition by generating profits of 76 percent, he chose another path. From his home far away from Wall Street, he specializes in providing advice that can guide Main Street Americans to successful investing in technology, small-cap stocks and other growth opportunities as Banyan Hill Publishing’s senior editor.
The remarkable gains that his stock picks produce may seem out of reach for an ordinary investor, but his subscription services show how he did it. He uses his more than 25 years of experience with the unique methods that he invented and owns to demonstrate hands-on trading to generate superior returns. As a practical illustration of his proven methods, he opened a demonstration account in January of 2016 with $5000 of real money, and his stock picks have already realized more than 180 percent. He cites Coeur Mining that saw an increase of 700 plus percent, and the account appears on his Capuchin Consulting website.